Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia

Wayne, AS; Van Huynh; Hijiya, N; Rouce, RH; Brown, PA; Krueger, J; Kitko, CL; Dela Ziga, E; Hermiston, ML; Richards, MK; Baruchel, A; Schuberth, PC; Rossi, J; Zhou, L; Goyal, L; Jain, R; Vezan, R; Masouleh, BK; Lee, DW

Wayne, AS (通讯作者),Univ Southern Calif, Childrens Hosp Los Angeles, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.;Wayne, AS (通讯作者),Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA.

HAEMATOLOGICA, 2023; 108 (3): 747

Abstract

Here we present the 3-year results of ZUMA-4, a phase I/II multicenter study evaluating the safety and efficacy of KTEX19, an autologous anti-CD19 chi......

Full Text Link